| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Net revenues | |||||||||
1,032 | 360 | 526 | - | - | - | - | - | - | - |
Net revenues | |||||||||
- | - | - | 327 | 159 | 3,343 | 3,318 | 911 | 99 | 0 |
Cost of revenues | |||||||||
397 | 248 | 308 | 319 | 780 | 1,420 | 1,521 | 863 | 49 | 0 |
Gross profit | |||||||||
635 | 112 | 218 | 8 | -621 | 1,923 | 1,797 | 48 | 49 | 0 |
Operating expenses: | |||||||||
Selling, marketing and research | |||||||||
1,276 | 894 | 822 | 846 | - | - | - | - | - | - |
Selling and marketing | |||||||||
- | - | - | - | 521 | - | - | - | - | - |
Research & development | |||||||||
- | - | - | - | - | 1,348 | 754 | - | - | - |
Personnel and benefits | |||||||||
1,897 | 1,718 | 1,450 | 1,853 | 1,556 | - | - | - | - | - |
Share-based compensation | |||||||||
- | - | - | - | 930 | - | - | - | - | - |
General and administrative | |||||||||
1,680 | 1,829 | 2,014 | 1,616 | 1,224 | - | 5,310 | 3,084 | 4,645 | 28 |
Selling, general and administrative | |||||||||
- | - | - | - | - | 5,621 | - | - | - | - |
Amortization of acquired intangibles | |||||||||
- | - | - | - | 210 | 154 | - | - | - | - |
Amortization | |||||||||
- | - | - | - | - | - | 0 | - | - | - |
Loss on asset impairment | |||||||||
- | - | - | - | 0 | 5 | - | - | - | - |
Loss on asset impairment | |||||||||
- | - | - | - | - | - | 0 | - | - | - |
Total operating expenses | |||||||||
4,853 | 4,441 | 4,286 | 4,315 | 4,441 | 7,128 | 6,064 | - | - | - |
Operating loss | |||||||||
-4,218 | -4,329 | -4,068 | -4,307 | -5,062 | -5,205 | -4,267 | -3,035 | -4,596 | -28 |
Other expense: | |||||||||
Interest expense | |||||||||
- | - | - | - | - | - | - | 801 | 24 | 0 |
Other expense, net | |||||||||
- | -2 | - | - | - | - | - | 0 | - | - |
Other (expense) income | |||||||||
- | - | 12 | 1 | - | - | - | - | - | - |
Interest income | |||||||||
- | - | - | - | 1 | 2 | 4 | 8 | 0 | - |
Interest expense | |||||||||
40 | 16 | 2 | 35 | 15 | 4 | 0 | - | - | - |
Value of warrants in excess of the amount of additional paid-in capital received in the related private placement of restricted common stock | |||||||||
- | - | - | - | - | - | - | - | -2,405 | 0 |
Change in fair value of warrants | |||||||||
- | - | - | - | - | - | - | -16 | -4,101 | - |
Change in fair value of warrants | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Impairment charge - intellectual property | |||||||||
- | - | - | - | - | - | - | 0 | 2,662 | 0 |
Amortization of deferred financing costs | |||||||||
- | - | - | - | - | - | - | 69 | 10 | 0 |
Gain on forgiveness of debt | |||||||||
- | - | - | - | - | - | - | 0 | 0 | 12 |
Total other expense | |||||||||
-40 | -18 | 10 | -34 | -14 | -2 | 4 | -878 | -1,001 | 12 |
Loss before income taxes | |||||||||
-4,258 | -4,347 | -4,058 | -4,341 | -5,076 | -5,207 | -4,263 | - | - | - |
Income tax benefit | |||||||||
- | -1,124 | - | 0 | 2 | -748 | 0 | - | - | - |
Net loss | |||||||||
-4,258 | -3,223 | -4,058 | -4,341 | -5,078 | -4,459 | -4,263 | -3,914 | -5,597 | - |
Deemed dividend resulting from warrant modification | |||||||||
- | - | - | - | -225 | 0 | - | - | - | - |
Net loss per share attributable to common shareholders: | |||||||||
- | - | - | - | -5,303 | -4,459 | - | - | - | - |
Net loss per share attributable to common shareholders: | |||||||||
Weighted average number of common shares outstanding, basic and diluted | |||||||||
- | - | - | - | - | - | - | - | - | 49,000 |
Basic and diluted | |||||||||
-0.46 | -0.45 | -0.69 | -0.90 | -1.64 | -1.56 | -1.93 | -2.13 | -0.09 | 0.00 |
Weighted average number of common shares outstanding: | |||||||||
Net income (loss) | |||||||||
- | - | - | - | - | - | - | - | - | -16 |
Basic and diluted | |||||||||
8,803 | 7,139 | 5,875 | 4 | 3 | 2,853 | 2,213 | 1,840 | 61,673 | - |